Lennar, Darden Restaurants, Novavax Fall Premarket;  Eli Lilly, HP Fuller Rise

Lennar, Darden Restaurants, Novavax Fall Premarket; Eli Lilly, HP Fuller Rise

Written by Peter Norse

Investing.com – Stocks are in focus in premarket trading on Thursday, Sept 22. Please update for updates.

  • linar Stock (NYSE:) fell 1.5% after the homebuilder reported better-than-expected results, buoyed by a record price rise, but new home sales disappointed.

  • Darden Restaurants NYSE stock fell: 3.3% after the owner of Olive Garden said sales of the same restaurant rose 4.2% during the quarter, less than expected.
  • HB Fuller (NYSE:) rose 2.2% after the adhesive company beat expectations, citing “strong pricing actions to restore unprecedented raw material cost inflation.”

  • Accenture (NYSE:) stock fell 0.3% after the IT services company forecast lower-than-expected first-quarter revenue, weighed down by IT spending cuts amid higher inflation and a stronger impact.

  • Eli Lilly Stock (NYSE:) rose 1.8% after UBS upgraded its investment position in the drug company to “buy” from “neutral,” citing the potential benefits of futures sales of a major weight-loss drug.

  • sales force (NYSE: 🙂 Stock rose 2.5% after the cloud-based software company announced plans for 25% operating margin by 2026, seeking to operate more efficiently.

  • targeting (NYSE:) stock rose 0.2% after the major retailer announced plans to hire up to 100,000 seasonal workers for the holiday season and start offering festive deals sooner than ever.

  • Manchester United (NYSE:) The English football club’s stock will be in focus after the English football club posted a net loss of £70.7 million for the three months to June 30, down from a loss of £107.7 million the previous year.

  • nike (NYSE:) is up 0.7% after RBC began covering the retailer in “outperform,” saying that “100lb gorilla in sportswear” is set to rise nearly 30%.

  • Novavax (NASDAQ 🙂 (NASDAQ) stock fell 5.7% after JPMorgan downgraded its stance on the drugmaker to “underweight” from “neutral”. Citing low demand for the vaccine.

READ ALSO :   Wall Street still hates cash more than stocks even as 'TINA' trade collapses and bond yields rise, Bank of America says

Newsletter Updates

Enter your email address below to subscribe to our newsletter